IBDEI093 ; ; 18-FEB-2009
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 18, 2009
 Q:'DIFQR(358.4)  F I=3D1:2 S X=3D$T(Q+I) Q:X=3D""  S
Y=3D$E($T(Q+I+1),4,999),X=3D$E(X,4,999) S:$A(Y)=3D126
I=3DI+1,Y=3D$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=3D61 Y=3D$E(Y,2,999) =
X NO E
S @X=3DY
Q Q
 ;;^UTILITY(U,$J,358.4)
 ;;=3D^IBE(358.4,
 ;;^UTILITY(U,$J,358.4,0)
 ;;=3DIMP/EXP SELECTION GROUP^358.4I^696^696
 ;;^UTILITY(U,$J,358.4,1,0)
 ;;=3DADJUSTMENT DISORDERS^1^1
 ;;^UTILITY(U,$J,358.4,2,0)
 ;;=3DANXIETY DISORDERS^3^1
 ;;^UTILITY(U,$J,358.4,3,0)
 ;;=3DAMNESTICS^2^1
 ;;^UTILITY(U,$J,358.4,4,0)
 ;;=3DORGANIC DISORDERS^9^1
 ;;^UTILITY(U,$J,358.4,5,0)
 ;;=3DDEMENTIA^5^1
 ;;^UTILITY(U,$J,358.4,6,0)
 ;;=3DDELIRIUM^4^1
 ;;^UTILITY(U,$J,358.4,7,0)
 ;;=3DBIPOLAR DISORDERS^3.5^1
 ;;^UTILITY(U,$J,358.4,8,0)
 ;;=3DPSYCHOSIS^12^1
 ;;^UTILITY(U,$J,358.4,9,0)
 ;;=3DPERSONALITY DISORDERS^11^1
 ;;^UTILITY(U,$J,358.4,10,0)
 ;;=3DSEXUAL DISORDERS^14^1
 ;;^UTILITY(U,$J,358.4,11,0)
 ;;=3DSLEEP DISORDERS^15^1
 ;;^UTILITY(U,$J,358.4,12,0)
 ;;=3DOTHER DISORDERS^19^1
 ;;^UTILITY(U,$J,358.4,13,0)
 ;;=3DSUBSTANCE RELATED DISORDERS^0^1
 ;;^UTILITY(U,$J,358.4,14,0)
 ;;=3DV CODES^17^1
 ;;^UTILITY(U,$J,358.4,15,0)
 ;;=3DPREVENTION/COUNSELING/SCREEN^20^1
 ;;^UTILITY(U,$J,358.4,16,0)
 ;;=3DDEPRESSION^6^1
 ;;^UTILITY(U,$J,358.4,17,0)
 ;;=3DMOOD DISORDERS (OTHER)^8^1
 ;;^UTILITY(U,$J,358.4,18,0)
 ;;=3DSCHIZOPHRENIA^13^1
 ;;^UTILITY(U,$J,358.4,19,0)
 ;;=3DSOMATIFORM DISORDERS^16^1
 ;;^UTILITY(U,$J,358.4,20,0)
 ;;=3DEATING DISORDERS^7^1
 ;;^UTILITY(U,$J,358.4,21,0)
 ;;=3DOTHER PROVIDER'S CODES^4^2
 ;;^UTILITY(U,$J,358.4,22,0)
 ;;=3DPRESCRIBER CODES^1^2
 ;;^UTILITY(U,$J,358.4,23,0)
 ;;=3DPSYCHOTHERAPY (MSW/PhD/Prescriber)^2^2
 ;;^UTILITY(U,$J,358.4,24,0)
 ;;=3DOTHER CODES^3^2
 ;;^UTILITY(U,$J,358.4,25,0)
 ;;=3DCOGNITIVE DISORDERS^1^3
 ;;^UTILITY(U,$J,358.4,26,0)
 ;;=3DDEVELOPMENTAL DISORDERS^3^3
 ;;^UTILITY(U,$J,358.4,27,0)
 ;;=3DLATE EFFECTS OF CEREBROVASCULAR DIS^5^3
 ;;^UTILITY(U,$J,358.4,28,0)
 ;;=3DVOCAL FOLD DISORDER^7^3
 ;;^UTILITY(U,$J,358.4,29,0)
 ;;=3DOTHER SPEECH DISORDERS^9^3
 ;;^UTILITY(U,$J,358.4,30,0)
 ;;=3DHISTORY OF MALIGNANCY^11^3
 ;;^UTILITY(U,$J,358.4,31,0)
 ;;=3DFACTOR INFLUENCING HEALTH^13^3
 ;;^UTILITY(U,$J,358.4,32,0)
 ;;=3DPSYCHOGENIC^15^3
 ;;^UTILITY(U,$J,358.4,33,0)
 ;;=3DSWALLOWING DISORDER^17^3
 ;;^UTILITY(U,$J,358.4,34,0)
 ;;=3DESTABLISHED PATIENT^2^4
 ;;^UTILITY(U,$J,358.4,35,0)
 ;;=3DEAR DISEASES^1^5
 ;;^UTILITY(U,$J,358.4,36,0)
 ;;=3DFACTOR INFLUENCING HEALTH^2^5
 ;;^UTILITY(U,$J,358.4,37,0)
 ;;=3DHEARING LOSS (HL)^14^5
 ;;^UTILITY(U,$J,358.4,38,0)
 ;;=3DOTHER^15^5
 ;;^UTILITY(U,$J,358.4,39,0)
 ;;=3DNYSTAGMUS^17^5
 ;;^UTILITY(U,$J,358.4,40,0)
 ;;=3DTREATMENT^1^6
 ;;^UTILITY(U,$J,358.4,41,0)
 ;;=3DGROUP TREATMENT^3^6
 ;;^UTILITY(U,$J,358.4,42,0)
 ;;=3DVOICE PROSTHESES^5^6
 ;;^UTILITY(U,$J,358.4,43,0)
 ;;=3DAAC DEVICES^7^6
 ;;^UTILITY(U,$J,358.4,44,0)
 ;;=3DOTHER PROCEDURES^9^6
 ;;^UTILITY(U,$J,358.4,45,0)
 ;;=3DLARYNGOSCOPY PROCEDURES^11^6
 ;;^UTILITY(U,$J,358.4,46,0)
 ;;=3DNASOPHARYNGOSCOPY^13^6
 ;;^UTILITY(U,$J,358.4,47,0)
 ;;=3DDYSPHAGIA EVALUATION^15^6
 ;;^UTILITY(U,$J,358.4,48,0)
 ;;=3DSPEECH/LANGUAGE/HEARING EVALUATION^17^6
 ;;^UTILITY(U,$J,358.4,49,0)
 ;;=3DSCREENING^23^6
 ;;^UTILITY(U,$J,358.4,50,0)
 ;;=3DAUDIOLOGIC FUNCTION TESTS^1^7
 ;;^UTILITY(U,$J,358.4,51,0)
 ;;=3DSCREENING^3^7
 ;;^UTILITY(U,$J,358.4,52,0)
 ;;=3DOTHER PROCEDURES^5^7
 ;;^UTILITY(U,$J,358.4,53,0)
 ;;=3DOTHER^11^7
 ;;^UTILITY(U,$J,358.4,54,0)
 ;;=3DCOCHLEAR IMPLANT^13^7
 ;;^UTILITY(U,$J,358.4,55,0)
 ;;=3DOTHER TREATMENT^15^7
 ;;^UTILITY(U,$J,358.4,56,0)
 ;;=3DDISPENSING^17^7
 ;;^UTILITY(U,$J,358.4,57,0)
 ;;=3DREMOVAL FOREIGN BODY/CERUMEN^19^7
 ;;^UTILITY(U,$J,358.4,58,0)
 ;;=3DVESTIBULAR FUNCTION TESTS(RECORDING)^21^7
 ;;^UTILITY(U,$J,358.4,59,0)
 ;;=3DVESTIBULA FUNCTION (OBSERVATION)^23^7
 ;;^UTILITY(U,$J,358.4,60,0)
 ;;=3DHA ORIENTATION^25^7
 ;;^UTILITY(U,$J,358.4,61,0)
 ;;=3DBLIND REHAB SERVICE CODES^1^8
 ;;^UTILITY(U,$J,358.4,62,0)
 ;;=3DOFFICE VISIT^1^9
 ;;^UTILITY(U,$J,358.4,63,0)
 ;;=3DCONTRIBUTORY COND (MARK ALL THAT APPLY)^3^10
 ;;^UTILITY(U,$J,358.4,64,0)
 ;;=3DLEGAL BLINDNESS/VISUAL IMPAIR (ADD ONE) ^2^10
 ;;^UTILITY(U,$J,358.4,65,0)
 ;;=3DPRIMARY^1^10
 ;;^UTILITY(U,$J,358.4,66,0)
 ;;=3DV CODES^4^10
 ;;^UTILITY(U,$J,358.4,67,0)
 ;;=3DMYOCARDIAL INFARCTION^9^11
 ;;^UTILITY(U,$J,358.4,68,0)
 ;;=3DCHF / MYOPATHY / TRANSPLANT^3^11
 ;;^UTILITY(U,$J,358.4,69,0)
 ;;=3DARRHYTHMIA^1^11
 ;;^UTILITY(U,$J,358.4,70,0)
 ;;=3DPERIPHERAL VASC DIS^10^11
 ;;^UTILITY(U,$J,358.4,71,0)
 ;;=3DINFECT/INFLAM DISEASE^7^11
 ;;^UTILITY(U,$J,358.4,72,0)
 ;;=3DSYNCOPE/HYPOTENSION^12^11
 ;;^UTILITY(U,$J,358.4,73,0)
 ;;=3DGENERAL SYMPTOMS^5^11
 ;;^UTILITY(U,$J,358.4,74,0)
 ;;=3DLIPID DISORDERS^8^11
 ;;^UTILITY(U,$J,358.4,75,0)
 ;;=3DSCREENING DEVICES^11^11
 ;;^UTILITY(U,$J,358.4,76,0)
 ;;=3DCHEST PAIN^2^11
 ;;^UTILITY(U,$J,358.4,77,0)
 ;;=3DCORONARY ATHEROSCLEROSIS^4^11
 ;;^UTILITY(U,$J,358.4,78,0)
 ;;=3DOTHER FORMS OF HEART DISEASE^13^11
 ;;^UTILITY(U,$J,358.4,79,0)
 ;;=3DHYPERTENSION^6^11
 ;;^UTILITY(U,$J,358.4,80,0)
 ;;=3DNONRHEUMATIC HEART VALVE DISEASE^14^11
 ;;^UTILITY(U,$J,358.4,81,0)
 ;;=3DRHEUMATIC HEART DISEASE^15^11
 ;;^UTILITY(U,$J,358.4,82,0)
 ;;=3DOTHER HEART VALVE DISEASE^16^11
 ;;^UTILITY(U,$J,358.4,83,0)
 ;;=3DPACEMAKER^5^12
 ;;^UTILITY(U,$J,358.4,84,0)
 ;;=3DCORONARY ANGIOPLASTY & STENTS^3^12
 ;;^UTILITY(U,$J,358.4,85,0)
 ;;=3DELECTROPHYSIOLOGICAL PROCs^4^12
 ;;^UTILITY(U,$J,358.4,86,0)
 ;;=3DINJECTIONS WITH HEART CATH^2^12
 ;;^UTILITY(U,$J,358.4,87,0)
 ;;=3DPERIPHERAL ANGIOPLASTIES & STENTS^7^12
 ;;^UTILITY(U,$J,358.4,88,0)
 ;;=3DVASCULAR INJECTION PROCs^8^12
 ;;^UTILITY(U,$J,358.4,89,0)
 ;;=3DOTHER PROCEDURES^9^12
 ;;^UTILITY(U,$J,358.4,90,0)
 ;;=3DHEART CATHETERIZATIONS^1^12
 ;;^UTILITY(U,$J,358.4,91,0)
 ;;=3DCATHETERIZATIONS FOR INT RADIOLOGY^6^12
 ;;^UTILITY(U,$J,358.4,92,0)
 ;;=3DHEART SUPERVISION AND INTERPRETATION^2.5^12
 ;;^UTILITY(U,$J,358.4,93,0)
 ;;=3DOTHER HEART CODES/ECHO^3.5^12
 ;;^UTILITY(U,$J,358.4,94,0)
 ;;=3DPROSTHETIC ANEURYSM REPAIR^10^12
 ;;^UTILITY(U,$J,358.4,95,0)
 ;;=3DEKG^1^13
 ;;^UTILITY(U,$J,358.4,96,0)
 ;;=3DOTHER CARDIAC^4^13
 ;;^UTILITY(U,$J,358.4,97,0)
 ;;=3DECHO^3^13
 ;;^UTILITY(U,$J,358.4,98,0)
 ;;=3DSTRESS TESTS^5^13
 ;;^UTILITY(U,$J,358.4,99,0)
 ;;=3DNEW PATIENT^2^14
 ;;^UTILITY(U,$J,358.4,100,0)
 ;;=3DESTABLISHED PATIENT^1^14
 ;;^UTILITY(U,$J,358.4,101,0)
 ;;=3DCONSULTATIONS^3^14
 ;;^UTILITY(U,$J,358.4,102,0)
 ;;=3DMYOCARDIAL INFARCTION^9^15
 ;;^UTILITY(U,$J,358.4,103,0)
 ;;=3DCHF / MYOPATHY / TRANSPLANT^3^15
 ;;^UTILITY(U,$J,358.4,104,0)
 ;;=3DARRHYTHMIA^1^15
 ;;^UTILITY(U,$J,358.4,105,0)
 ;;=3DPERIPHERAL VASC DIS^10^15
 ;;^UTILITY(U,$J,358.4,106,0)
 ;;=3DINFECT/INFLAM DISEASE^7^15
 ;;^UTILITY(U,$J,358.4,107,0)
 ;;=3DSYNCOPE/HYPOTENSION^12^15
 ;;^UTILITY(U,$J,358.4,108,0)
 ;;=3DGENERAL SYMPTOMS^5^15
 ;;^UTILITY(U,$J,358.4,109,0)
 ;;=3DLIPID DISORDERS^8^15
 ;;^UTILITY(U,$J,358.4,110,0)
 ;;=3DSCREENING DEVICES^11^15
 ;;^UTILITY(U,$J,358.4,111,0)
 ;;=3DCHEST PAIN^2^15
 ;;^UTILITY(U,$J,358.4,112,0)
 ;;=3DCORONARY ATHEROSCLEROSIS^4^15
 ;;^UTILITY(U,$J,358.4,113,0)
 ;;=3DOTHER FORMS OF HEART DISEASE^13^15
 ;;^UTILITY(U,$J,358.4,114,0)
 ;;=3DHYPERTENSION^6^15
 ;;^UTILITY(U,$J,358.4,115,0)
 ;;=3DNONRHEUMATIC HEART VALVE DISEASE^14^15
 ;;^UTILITY(U,$J,358.4,116,0)
 ;;=3DRHEUMATIC HEART DISEASE^15^15
 ;;^UTILITY(U,$J,358.4,117,0)
 ;;=3DOTHER HEART VALVE DISEASE^16^15
 ;;^UTILITY(U,$J,358.4,118,0)
 ;;=3DNEW PATIENT^2^16
 ;;^UTILITY(U,$J,358.4,119,0)
 ;;=3DESTABLISHED PATIENT^1^16
 ;;^UTILITY(U,$J,358.4,120,0)
 ;;=3DCONSULTATIONS^3^16
 ;;^UTILITY(U,$J,358.4,121,0)
 ;;=3DMISCELLANEOUS TREATMENT^3^17
 ;;^UTILITY(U,$J,358.4,122,0)
 ;;=3DCHIROPRACTIC MANIPULATIVE SERVICES^0^17
 ;;^UTILITY(U,$J,358.4,123,0)
 ;;=3DMUSCULOSKELETAL/CONNECTIVE TISSUE^7^18
 ;;^UTILITY(U,$J,358.4,124,0)
 ;;=3DBLANK^0^19
 ;;^UTILITY(U,$J,358.4,125,0)
 ;;=3DC&P EXAM^1^20
 ;;^UTILITY(U,$J,358.4,126,0)
 ;;=3DLENGTHY/COMPLEX C-FILE REVIEW^1^21
 ;;^UTILITY(U,$J,358.4,127,0)
 ;;=3DNEW PATIENT^2^22
 ;;^UTILITY(U,$J,358.4,128,0)
 ;;=3DESTABLISHED PATIENT^1^22
 ;;^UTILITY(U,$J,358.4,129,0)
 ;;=3DCONSULTATIONS^3^22
 ;;^UTILITY(U,$J,358.4,130,0)
 ;;=3DDEBRIDEMENT^1^23
 ;;^UTILITY(U,$J,358.4,131,0)
 ;;=3DDESTRUCTION-BENIGN OR PREMALIG LESIONS^2^23
 ;;^UTILITY(U,$J,358.4,132,0)
 ;;=3DDESTRUCTION-MALIGNANT LESIONS^3^23
